Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 55 out of 100. Disease mechanisms

Topic: Brain proteins, microglia and lab models

Plain-language summary

Aggregation of the protein tau defines tauopathies, the most common age-related neurodegenerative diseases, which include Alzheimer's disease and frontotemporal dementia. Specific neuronal subtypes are selectively vulnerable to tau aggregation, dysfunction, and death. However, molecular mechanisms underlying cell-type-selective vulnerability are unknown. To systematically uncover the cellular factors controlling the accumulation of tau aggregates in human neurons, we conducted a genome-wide CRISPRi screen in induced pluripotent stem cell (iPSC)-derived neurons. The screen uncovered both known and unexpected pathways, including UFMylation and GPI anchor biosynthesis, which control tau oligomer levels. We discovered that the E3 ubiquitin ligase CRL5 SOCS4 controls tau levels in human neurons, ubiquitinates tau, and is correlated with resilience to tauopathies in human disease. Disruption of mitochondrial function promotes proteasomal misprocessing of tau, generating disease-relevant tau proteolytic fragments and changing tau aggregation in vitro . These results systematically reveal principles of tau proteostasis in human neurons and suggest potential therapeutic targets for tauopathies.

What this study adds

Evidence grade: Low

A genome-wide CRISPR screen in human iPSC-derived neurons identified cellular pathways and the E3 ubiquitin ligase CRL5 SOCS4 that control tau levels and aggregation. These results suggest possible therapeutic targets for tauopathies, but they come from laboratory cell models and no treatment has been tested in patients.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Samelson, A. J., Ariqat, N., McKetney, J., Rohanitazangi, G., Bravo, C., Bose, R., et al. (2026). CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis. Cell. https://doi.org/10.1016/j.cell.2025.12.038

Vancouver

Samelson AJ, Ariqat N, McKetney J, Rohanitazangi G, Bravo C, Bose R, et al. CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis. Cell. 2026. doi:10.1016/j.cell.2025.12.038. PMID: 41610849.

BibTeX

@article{samelson2026-41610849,
  author  = {Samelson, Avi J. and Ariqat, Nabeela and McKetney, Justin and Rohanitazangi, Gita and Bravo, C and Bose, Rudra and Travaglini, Kyle J. and Lam, Victor L. and others},
  title   = {{CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis}},
  journal = {Cell},
  year    = {2026},
  doi     = {10.1016/j.cell.2025.12.038},
  pmid    = {41610849},
  url     = {https://doi.org/10.1016/j.cell.2025.12.038}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

A genome-wide CRISPR screen in human iPSC-derived neurons identified cellular pathways and the E3 ubiquitin ligase CRL5 SOCS4 that control tau levels and aggregation. These results suggest possible therapeutic targets for tauopathies, but they come from laboratory cell models and no treatment has been tested in patients.

Study details

How this study scored 55/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 4 of 7; Citations per year 4 of 5; Impact for its field and year 6 of 6; Cited by studies here 0 of 6; Still being cited 3 of 4; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 55 of 100.55 of 100 points earned45 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Cell)
Journal's citation record 4 / 4 Cell: journal h-index 1,220 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Laboratory or animal study (title names “ipsc”) — scores zero
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 59 times (OpenAlex, 2026-10-10)
Citations per year 4 / 5 29.5 citations a year over 2 year(s) since 2026
Impact for its field and year 6 / 6 Cited 124.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 3 / 4 Cited 56 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Martin Kampmann: h-index 56 (OpenAlex, whole career)
Institution's track record 2 / 3 Howard Hughes Medical Institute: institution h-index 2,008 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 8 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41610849)
Free to read 2 / 2 Free to read
Total 55 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

In the news

1 news article on alzhub's news page cites this paper.

Related studies in Disease mechanisms from nearby years

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Disease mechanisms

See all studies in Disease mechanisms →